Acute vascular effects of nanoparticle infusion in isolated perfused skin

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 4, 2012, Pages 428-431

  Riviere, Jim E ^a   Leavens, Teresa L ^a   Brooks, James D ^a   Monteiro Riviere, Nancy A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Biodistribution; In vitro; Nanoparticles; Vascular toxicity

Indexed keywords

BIODISTRIBUTIONS; BIOLOGICAL FUNCTIONS; DATA SETS; DERMAL EXPOSURE; EX-VIVO; IN-VITRO; IN-VIVO; NANOMATERIAL; PHYSIOLOGICAL EFFECTS; PORCINE SKIN; TISSUE PREPARATION; VASCULAR EFFECTS; WEIGHT GAIN;

NANOPARTICLES; NANOSTRUCTURED MATERIALS; ORGANIC CHEMICALS; PHYSIOLOGY; SILICA; TISSUE;

SILVER;

DEXTRAN; MACROGOL; NANOMATERIAL; NANOPARTICLE; QUANTUM DOT; SILICON DIOXIDE;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; IN VITRO STUDY; IN VIVO STUDY; INFUSION; NONHUMAN; SKIN FLAP; SWINE; TISSUE PREPARATION; VASCULAR TISSUE; WEIGHT GAIN;

ANIMALS; FEMALE; PERFUSION; QUANTUM DOTS; SKIN; SUS SCROFA; VASCULAR RESISTANCE;

SUS;

EID: 84860239546     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.02.016     Document Type: Article

References (11)

1. Monteiro-Riviere N.A., Tran L. Nanotoxicology: characterization, dosing, and health effects 2007, Informa Healthcare, New York.
2. Praetner M., Rehberg M., Bihari P., Lerchenberger M., Uhl B., Holzer M., et al. The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo. Biomaterials 2010, 31:6692-6700.
3. Lee H.A., Imran M., Monteiro-Riviere N.A., Colvin V.L., Wu W., Riviere J.E. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007, 7:2865-2870.
4. Kreyling W.G., Semmler-Behnke M., Mooler W. Health implications of nanoparticles. J Nanoparticle Res 2006, 8:543-562.
5. Riviere J.E., Bowman K.F., Monteiro-Riviere N.A., Dix L.P., Carver M.P. The isolated perfused porcine skin flap (IPPSF): I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam Appl Toxicol 1986, 7:444-453.
6. Monteiro-Riviere N.A. Specialized technique: isolated perfused porcine skin flap. Methods for skin absorption 1990, 175-189. CRC Press, Inc. B.W. Kemppainen, W.G. Reifenrath (Eds.).
7. Williams P.L., Riviere J.E. Definition of a physiologic pharmacokinetic model of cutaneous drug distribution using the isolated perfused porcine skin flap (IPPSF). J Pharm Sci 1989, 78:550-555.
8. Rogers R.A., Riviere J.E. Pharmacologic modulation of the cutaneous vasculture in the isolated perfused porcine skin flap (IPPSF). J Pharm Sci 1994, 83:1682-1689.
9. Leavens T.L., Xia X.R., Lee H.Y., Monteiro-Riviere N.A., Brooks J.D., Riviere J.E. Evaluation of perfused porcine skin as a model system to quantitate tissue distribution of fullerene nanoparticles. Toxicol Lett 2010, 197:1-6.
10. Sommer A.P. Cytotoxicity of calcium phosphate crystals and human-derived nanoparticles: an observed link. Circ Res 2010, 106:e10.
11. Moller P., Mikkelsen L., Vesterdal L.K., Folkmann J.K., Forchhammer L., Roursgaard M., et al. Hazard identification of particulate exposure on vasomotor dysfunction and progression of atherosclerosis. Crit Rev Toxicol 2011, 41:339-368.